Report assessing the portfolio of new technologies published
A new report launched at a special meeting of the All Party Parliamentary Group for Malaria at Westminster, assesses a portfolio of new technologies, collectively known as The Artemisinin Enterprise:
- The Centre for Novel Agricultural Products at the University of York is using fast-track plant breeding to increase yields of artemisinin from the medicinal plant
- Institute for One World Health is using synthetic biology to produce artemisinin through fermentation and subsequent chemical conversion;
- Medicines for Malaria Venture is developing novel synthetic artemisinin-like compounds.
Today’s report concludes that the outputs from all three technologies can collectively help satisfy the projected global demand for malaria treatments by providing alternative sources of artemisinin, stabilising the supply of effective antimalarial drugs such as ACTs and reducing the cost of artemisinin production.